Non-invasive Prenatal Testing (NIPT) Market is expected to reach $2.88 billion by 2021, at a CAGR of 16.4%

Non Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

ID: 1542507
recent pressrelease next pressrelease

(businesspress24) - According to the new market research report & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets

Early buyers will receive 10% customization on reports.

The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.

The market in this report is segmented on the basis of product, method, application, end user, and region. Based on product, the market is segmented into consumables and instruments. The consumable segment is further divided into assay kits & reagents and disposables. The instruments segment is divided into ultrasound device, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT.

Based on method, the market is further divided into ultrasound detection, biochemical screening tests, fetal cells in maternal blood tests, and cell-free DNA in maternal plasma tests. In 2016, the ultrasound detection accounted for the largest share of the market. However, the cell-free DNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. This is mainly attributed to the increasing demand for cf-DNA based techniques in NIPT testing and rising government initiatives to provide prenatal services.

Based on application, the market is divided into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest and fastest-growing application segment of the global market. This is mainly attributed to the rising incidence of chromosomal abnormalities with increasing maternal age.

Based on end user, the market is segmented into diagnostic laboratories and hospitals. In 2016, the diagnostic laboratories segment accounted for the largest share of the market. Growth in this end-user segment can be attributed to the rising incidence of chromosomal abnormalities and increasing initiatives by companies to provide advanced products in NIPT to diagnostic laboratories.

110 - Tables

48 - Figures

150 - Pages

View more detailed TOC (at)

N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

Request for Free Sample Report (at)

Browse Adjacent Markets (at) Biotechnology Market Research Reports & Consulting
About MarketsandMarkets


Our 850 fulltime analyst and SMEs at MarketsandMarkets"Growth Engagement Model ". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets"Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Mr. Shelly Singh

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales(at)
Research Insight:

Visit Our Website:

More information:

Keywords (optional):

non, invasive-prenatal-testing-nipt-market,

Company information / Profile:

PressRelease by


PressContact / Agency:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales(at)

published by:
print pressrelease  send to a friend  

Date: 10/11/2018 - 15:17
Language: English
News-ID 1542507
Character count: 6462
Firma: marketsandmarkets
Ansprechpartner: Feedback to about Pressrelease-id:

Meldungsart: Erfolgsprojekt
Versandart: Veröffentlichung

Number of hits: 361


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 237
Register today: 5
Register yesterday: 5
Members online: 0
Guests online: 47

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.